Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Fleisch

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Critical Care Medicine|December 1, 1993
A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine modelM P Fink, B P O'Sullivan, M J Menconi, et al.
Journal of Medicinal Chemistry|September 1, 1991
(Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonistsR D Dillard, R A Hahn, D McCullough, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) releaseJ H Fleisch, K D Haisch, S M Spaethe, et al.
Agents and Actions|June 1, 1989
Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647W S Marshall, S K Sigmund, C A Whitesitt, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonistsR W Harper, D K Herron, N G Bollinger, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1990
Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883L E Rinkema, C R Roman, W L Russell, et al.
European Journal of Pharmacology|November 23, 1992
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonistS A Silbaugh, P W Stengel, S L Cockerham, et al.
Journal of Medicinal Chemistry|October 27, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonistJ S Sawyer, N J Bach, S R Baker, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Critical Care Medicine|December 1, 1993
A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine modelM P Fink, B P O'Sullivan, M J Menconi, et al.
Journal of Medicinal Chemistry|September 1, 1991
(Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonistsR D Dillard, R A Hahn, D McCullough, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonistJ H Fleisch, L E Rinkema, K D Haisch, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) releaseJ H Fleisch, K D Haisch, S M Spaethe, et al.
Agents and Actions|June 1, 1989
Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647W S Marshall, S K Sigmund, C A Whitesitt, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonistsR W Harper, D K Herron, N G Bollinger, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1990
Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883L E Rinkema, C R Roman, W L Russell, et al.
European Journal of Pharmacology|November 23, 1992
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonistS A Silbaugh, P W Stengel, S L Cockerham, et al.
Journal of Medicinal Chemistry|October 27, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonistJ S Sawyer, N J Bach, S R Baker, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
Pageof 5